Bioimpedance Resistance Indices and Cell Membrane Capacitance Used to Assess Disease Status and Cell Membrane Integrity in Children with Nephrotic Syndrome

Table 3

Clinical data for the ANS patients.

Parameters / Patients	1	2	3	4	5	6	7	8
Sex	M	F	M	M	M	M	M	M
Age (years, months)	5,2	7, 8	4,11	2,2	8,8	9,11	11,2	4,3
Blood pressure (mmHg)	109/71	130/93	109/68	110/70	116/77	133/73	109/56	88/62
Hypertension^† (yes/no)	yes	yes	no	yes	no	yes	no	no
Pulse (bpm)	155	77	92	109	104	99	102	97
P-Albumin (g/L)	7	9	9	10	9	9	4	10
P-sodium (mmol/L)	131	132	137	139	129	137	127	141
P-potassium (mmol/L)	3.5	4.9	5.5	3.5	5.0	3.8	3.9	3.6
P-creatinine (μmol/L)	21	71	24	18	50	56	50	30
eGFR^‡ (ml/min/1.73m^2)	195	65	167	177	94	94	108	123
B-hemoglobin (mmol/L)	8.5	9.3	8.1	8.5	9.4	8.7	10.6	7.9

Patients in the subgroup ANS, which were restudied at remission, see Table 1.
^†Hypertension defined as blood pressure above the 95% percentile for high and gender; ^‡eGFR estimated by the Schwartz formula [19]. Reference ranges: P-Albumin (37-48), P-Sodium (137-145), P-potassium (3.5-4.6), and B-hemoglobin (6.5-8.9).